製薬 × マーケットアクセス / プライシング / HEOR の求人情報一覧
-
求人番号：JN -072024-38976 掲載日：2024-09-13
Director: RWE Partnerships & Innovation
Director position at global mega pharma1600 - 3000 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- The RWE Partnerships and Platforms organization functions to:Enhance company's ability to determine unmet medical needs;
Support differentiated product labels for Product Development programs including finding alternatives and accelerated licensure pathways for new indications through the use of Real World Data (RWD), Real World Insights (RWI) and Real World Evidence (RWE);
Inform clinical practice on appropriate prescription and use of company products;
In collaboration with Access & Value, strengthen the value evidence package for payers and access/policy decision-makers;
Support measurement of short- and long-term impact of company products to both patients and populations;
Support competitive differentiation.
This position will serve as the Real World Data point of contact for either one category or one geographic region.Execute on prioritized tactical plans with actionable projects, identify external partners to deliver strategic RWE capabilities / data, and oversight of high quality methods and designs to inform study / project designs for R&D franchise / asset teams, CMAO, Health Economics and Outcomes Research, Commercial and other functions’ needs
Provide daily mentorship, motivation, and guidance to more junior RWE colleagues, & direct them to co-develop emerging, core a strategic partnerships with commercial and academic data suppliers
Supports landscape assessments, new data / tool / partner due diligence assessments based on understanding evolving healthcare, technology and other industries with Customers, RWE Digital platform team, Digital RWD Enterprise Enabling Platform, RWE Biostatistics and other relevant partners
Documents all requests and track progress toward project completion, other metrics and business goals
Develops training materials for ensuring colleagues understanding and competency in various aspects of the RWE process
Communicates critical knowledge on business processes to relevant stakeholders
Yui Osone
Pharma -
求人番号：JN -072024-168087 掲載日：2024-09-13
ヘルスケアアフェアーズプランニングマネージャー
製薬業界での最低5年の経験をお持ちの方必見です。980 - 1400 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は本格的な研究・開発で医療に本質的に貢献できる医薬品の開発に力を注いでいる製薬会社です。非上場であるため、株主の意向に左右されず、戦略的な研究開発に専念し堅実な経営で長期的に安定して業績を拡大しています。また、人材育成にも力を入れており、社員には様々な成長の機会が提供されています。「人を切らない経営」として注目を浴びるなど、グローバルレベルでの人財育成に熱心な社風です。
- 業務内容
- 各疾患領域（TA/Therapeutic Area)、Medical、CAなどの社内ビジネス機能との連絡役として行動し、幅広いMAHA(Market Access, External Affairs, HEOR, Pricing, Distribution Management, Patient Engagement, Regional Access)イニシアチブを調整および統合します。
全社的およびTA／資産／対象疾患固有の視点を理解した上で、ヘルスケア・アフェアーズ・プランを他の部門横断的なプラン（IBP、ICP、LRなど）と有機的に組み合わせて同期させ、MAHA活動が会社と整合するようにします。
戦略とTA・資産戦略は、同時に外部環境とその変化を正しく理解し、早期に自社戦略、TA・資産戦略、MAHA戦略など、さまざまなレベルの戦略に反映させます。
Martin Tsvetkov
Pharma -
求人番号：JN -072024-166756 掲載日：2024-09-11
Access Strategy Senior Manager
Senior Manager position at global mega pharma1200 - 1800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- Overview:Develop a compelling access strategy tailored for New Asset to stakeholder interests and needs and leads strategic & tactical planning for market access activities to ensure optimal patient access with appropriate price setting.
Drive a Local/Regional/Global cross-functional team to develop and implement access strategies for assigned assets.
Scrutinize the commercialization plan for the assigned asset from pricing &reimbursement perspectives
Obtain endorsements from TA Leads to implement access strategies.
Main Responsibilities:Develop and implement access plans for assigned assets, which include scenario-based pricing assumptions with strategic initiatives, secure patient access and identify opportunities for accelerating launch timing.
Investigate and build deep understandings of key stakeholders’ (payers, market access customers) needs and reflect these insights into business/access planning processes via leveraging real-world databases and information in the following areas: Epidemiology: Patient dynamics, pathology, genetic background, Diagnosis & treatment guidelines
Market Environment: Current market size, competitive landscape analysis
Physician/Patient/Payer Insights: Unmet medical needs, burden of Disease/QOL
Local/Overseas access environment: Policy, HTA/Reimbursement system
Lead discussions and presentations to senior management to get required funding for launch optimization projects, including HEOR, HTA, RWD based data generation, as well as unbranded campaigns, etc., identified through cross functional discussion.
Work in close alignment and cooperation with a cross-section of colleagues (Global Access & Value, Global Commercial Development, Global Medicine Team, MA, DJ, Business Unit, A&V, P&PA, and BAI) through JMT/JVT/JAT.
Participate in JDC/J-PRC for portfolio entry, Global DP3 and Japan buy-up etc. through asset assessment in related TA as required.
Develop and include value claims for the brand at NDA to support optimal access.
Support NAA on developing reasonably accurate Long-rage revenue/expense/demand forecast for company pipeline assets and BD projects until 18 months prior to approval.
Support NAA on developing data, insights and recommendations for Strategic Plans that include strategies, tactics, and programs to maximize the long-term potential of development compounds, and obtain senior management endorsement.
Yui Osone
Pharma -
求人番号：JN -072024-169169 掲載日：2024-09-11
HEOR担当
医療経済評価モデル、観察研究、PRO/QOL研究の経験をお持ちの方必見です。500 - 1260 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は本格的な研究・開発で医療に本質的に貢献できる医薬品の開発に力を注いでいる製薬会社です。非上場であるため、株主の意向に左右されず、戦略的な研究開発に専念し堅実な経営で長期的に安定して業績を拡大しています。また、人材育成にも力を入れており、社員には様々な成長の機会が提供されています。「人を切らない経営」として注目を浴びるなど、グローバルレベルでの人財育成に熱心な社風です。
- 業務内容
- AT/eELとの連携により資産価値を最大化するための証拠生成戦略を策定し、現地のニーズを企業の資産戦略や成果物（AEP、IAPなど）に反映します。
HEOR 戦略に関する責任ある資産の取り組みについて、部門を超えて議論し、RWE 生成を含む HEOR 研究を主導します。
研究計画、医学的執筆、出版資料、結果の普及を含む、証拠生成の全プロセスに責任を負います。臨床開発における有用性を含むCOAの評価、企業AT/企業HEORとの連携によるCOAツールの検証または新規開発
Patrick Chang
Pharma -
求人番号：JN -072024-141505 掲載日：2024-09-11
Analyst
Analyst600 - 1000 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- This is the exclusive business partner and adviser to biopharma senior management teams
- 業務内容
- Demonstrated ability to be an important contact for the client in all communications
Ability to present independently to the client
Demonstrates strong understanding of assets that best fit the client
Ability to interact with partners and manage diligence requests
Able to trouble shoot assessment to evaluate target niches
Basic understanding of financial analysis and modelling, including DCF models and comparable transactions
Ability to author thought leadership pieces
Provide support in quality control and in ensuring the product is polished for Associate review
Having experience and understanding of the health care industry
Martin Tsvetkov
Pharma -
求人番号：JN -072024-37929 掲載日：2024-09-11
Pricing & External Affairs Senior Manager
Pricing Senior Manager position at global mega pharma1200 - 1800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- Responsibilities
Develop strategic NHI pricing strategies and gain endorsement of NHI pricing strategies and proposals of NHI prices with Country President and TA Leads through the Pricing Committee
Develop robust pricing dossiers and strategically manage price negotiations
Build strong alignment & partnership among Japan Pricing Core members (New Asset & Access Strategy team, New Asset Analysis team, DJ, Medical, Launch Excellence Team, Policy and Public Affairs, and the global PHI) to ensure optimal price setting
Develop Pricing-related OP assumptions
Refresh pricing assumptions and estimated prices for pipeline products and BD assets to reflect the latest competitive environment
Minimize the downward price adjustment by price revision/repricing through cross-functional collaboration
Maintain good relationship with “Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, MHLW” (former EAD) and act as a mediator between the company and MHLW to flawlessly manage all product-related issues, as well as NHI pricing negotiation
Actively participate in trade association activities (FPMAJ, PhRMA, FIRM, etc.) to establish a pro-innovative pricing framework
Contribute to building a high performing team by actively engaging in coaching junior colleagues and nurturing a positive environment where people feel energized and eager to speak up
Yui Osone
Pharma
1